Leading experts from major cancer centers worldwide to gather at Samsung Medical Center to discuss AI in cancer care

[Financial News] Medical professionals from major cancer centers around the world and representatives of global hospital-ranking organizations will gather at Samsung Medical Center (SMC) to discuss the future of cancer care in the age of artificial intelligence (AI). Changes across healthcare—from AI-powered precision diagnosis to personalized treatment, surgery and care for cancer survivors—are expected to be key topics.
Samsung Comprehensive Cancer Center announced on the 6th that it will hold the 7th Samsung Comprehensive Cancer Center Symposium on November 21, starting at 9 a.m., in the auditorium on the cancer center’s basement level 1 and the medium-sized lecture hall on basement level 2.
This year’s symposium is themed “AI Transformation: A New Standard Across the Entire Cancer Care Journey.” Representatives of major cancer centers will attend, including the U.S. Memorial Sloan Kettering Cancer Center, ranked No. 1 globally in Newsweek’s cancer hospital rankings; France’s Gustave Roussy, ranked No. 3; and Germany’s Charité – Universitätsmedizin Berlin, ranked No. 10. Statista, the German market research firm commissioned to conduct Newsweek’s hospital rankings, will also participate.
The four sessions will address changes in cancer care driven by AI and the direction of advances in precision medicine. In the first session, Fabrice Barlesi, director of Gustave Roussy, will present on approaches to standardizing AI at comprehensive cancer centers. Participants will also discuss AI-powered precision diagnosis and the use of multimodal data.
In the second session, Dominique Paul Modest, head of the cancer center at Charité, will introduce personalized treatment. Dr. Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center will present online on AI research in hepatobiliary and pancreatic cancers. Precision oncology and directions for developing future therapies will also be key topics.
Dr. Ji-woong Kim of Stanford University will participate online in the third session, which focuses on AI-assisted surgery. Jung Yong Gi, a professor of otolaryngology at SMC, will introduce research on Orchestra, a humanoid surgical-assistance robot being developed as part of a Korean ARPA-H project.
In the fourth session, Matthias Hirsch, Statista’s vice president of healthcare, will draw on his experience with global hospital rankings to present on value-based care in oncology and standardized approaches to evaluation and measurement. A separate nursing session will discuss digital-based care strategies for older cancer patients in response to the challenges of a super-aged society.
Kim Hee-chul, director of Samsung Comprehensive Cancer Center, said, “As AI, big data and wearable sensors are applied in healthcare settings and everyday life, an era in which patients’ conditions can be monitored in real time is becoming a reality.” He added, “This will be an opportunity to discuss changes in healthcare in the age of AI transformation with experts from Korea and abroad.”
Advance registration is available on the symposium website through November 13, and the registration fee is 10,000 won. On-site registration costs 20,000 won. The main sessions will be worth five continuing medical education credits from the Korean Medical Association (KMA).

[email protected] Jung Sang-hee Reporter